Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

Monday’s Trading Day
48.48 -0.50 / -1.02%
As of Aug 03
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
48.50 +0.02 / +0.04%
 
Volume: 310.00
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$24.5B

Company Description

Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company manages its operations in four geographic regional segments: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific. Within each of these regions, it offers a diversified product portfolio, including vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceuticals, for both livestock and companion animal customers. The company's origin dates back to Jan 1, 1952, when it was established as a division of Pfizer, Inc. Zoetis was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
100 Campus Drive
Florham Park New Jersey 07932
P:(973) 822-7000
Investor Relations:

Employees

Shareholders

Other institutional54.61%
Mutual fund holders38.57%
Individual stakeholders25.61%

Top Executives

Juan Ramón AlaixPresident, Chief Executive Officer & Director
Paul S. HerendeenChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Alejandro BernalExecutive Vice President & President-EMEA Region
Clinton A. LewisExecutive VP & President-International Operations